Clinical trials of pain medication often produce less-than-ideal results because the control group, or patients receiving a placebo, often improve more than expected. A team of researchers will explore how the design of chronic and acute pain trials can be improved.
Related Articles on Pain Management:
Physicians Struggle to Treat Pain During Opioid Abuse Epidemic
Study: Naltrexone Use Prevents Relapse of Opioid Dependency
Nano-formulated NSAIDs Provide Relief at Lower Doses
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.